EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for RHHBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 2.417
December 31, 2025 2.403
June 30, 2025 1.699
December 31, 2024 1.457
June 30, 2024 1.862
December 31, 2023 1.982
June 30, 2023 1.847
December 31, 2022 2.024
June 30, 2022 2.364
December 31, 2021 2.216
June 30, 2021 2.232
December 31, 2020 2.194
June 30, 2020 1.920
December 31, 2019 1.961
June 30, 2019 1.716
December 31, 2018 1.567
June 30, 2018 1.570
December 31, 2017 1.272
June 30, 2017 1.419
December 31, 2016 1.413
June 30, 2016 1.345
December 31, 2015 1.339
June 30, 2015 1.375
December 31, 2014 1.488
June 30, 2014 1.726
Date Value
December 31, 2013 1.742
June 30, 2013 1.723
December 31, 2012 1.472
June 30, 2012 1.378
December 31, 2011 1.545
June 30, 2011 1.300
December 31, 2010 1.201
June 30, 2010 1.338
December 31, 2009 1.046
June 30, 2009 0.9829
December 31, 2008 1.195
June 30, 2008 1.245
December 31, 2007 1.163
June 30, 2007 1.022
December 31, 2006 0.9007
June 30, 2006 0.7945
December 31, 2005 0.6913
June 30, 2005 0.509
December 31, 2004 0.4309
June 30, 2004 0.4617
December 31, 2003 0.3328
June 30, 2003 -0.4467
December 31, 2002 -0.424
June 30, 2002 0.2687
December 31, 2001 0.322

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Novartis AG 6.629
Eli Lilly & Co. 29.43
AstraZeneca PLC 3.330
Merck & Co., Inc. 1.251
Pfizer Inc. 0.7552